AI Insights · Timothy · April 2024
Top 5 Medical Apps in Oceania for Q1 2024
Explore the performance of the top 5 medical apps in Oceania during Q1 2024, including trends in weekly downloads, revenue, and active users.
During the first quarter of 2024, the top 5 medical apps in Oceania showed varying performance trends in terms of weekly downloads, revenue, and active users. Here’s a closer look at how each app fared.
Huckleberry: Baby & Child from Huckleberry Labs Inc. saw a steady weekly revenue, peaking at around $8.6K in mid-March. Weekly downloads fluctuated, with the highest being 2.5K in mid-January. The app maintained a strong user base, ending the quarter with approximately 41.3K active users.
Monash FODMAP Diet by Monash University experienced relatively stable weekly revenue, reaching a high of $3.8K in mid-March. Downloads were on a downward trend, starting at 976 in early January and dropping to 455 by the end of March. Weekly active users remained consistent, averaging around 7K.
SnoreLab : Record Your Snoring from Reviva Softworks Ltd showed an upward trend in weekly revenue, peaking at $4.7K in the last week of March. Downloads were consistent, averaging around 1K per week. Active users saw a slight increase, averaging around 4.1K throughout the quarter.
Ausmed - CE Portfolio App by Ausmed Education had moderate weekly revenue, with a peak of $3.6K at the end of February. Downloads showed an upward trend, reaching 994 in mid-March. Unfortunately, data on active users was not available.
Complete Anatomy for iPad from 3D4Medical from Elsevier saw significant growth in weekly revenue, peaking at $3.9K in late February. Downloads varied, with a peak of 1.3K in the same period. Active users also increased, reaching a high of 2K in late February before stabilizing around 1.3K by the end of March.
These insights are derived from Sensor Tower data, offering a detailed view of the performance trends for these top medical apps in Oceania. For more in-depth analysis and additional insights, visit Sensor Tower.